3 Results for "

RAT1 cell

" in MedChemExpress (MCE) Product Catalog:
Products (3)

3 Results for "RAT1 cell" in MCE Product Catalog:

Cat. No.: HY-164549
CAS No.: 1240489-67-1
Target:  

RET

Research Areas:  

Cancer

XMD15-44 is a RET kinase inhibitor.XMD15-44 has a growth-inhibitory effect on RET/C634R and RET/M918T transformed RAT1 cells, with IC50 values of 11.5 nM and 8.3 nM, respectively. XMD15-44 can inhibit RET kinase and signaling in human thyroid cancer cell lines carrying oncogenic RET alleles, reducing cell proliferation .
loading...
    loading...
Cat. No.: HY-163368
CAS No.: 1432508-73-0
Target:  

HDAC

Research Areas:  

Inflammation/Immunology

HDAC6-IN-34 (compound 21) is an oral active and selective HDAC6 inhibitor with the IC50 of 18 nM. HDAC6-IN-34 increases the acetylation level of tubulin without affecting histone acetylation in cutaneous T-cell lymphoma cells and inhibits TNF-α secretion in LPS (HY-D1056)-stimulated macrophage cells. HDAC6-IN-34 shows excellent anti-arthritic efficacy in rat .
loading...
    loading...
Cat. No.: HY-183931
CAS No.: 1839155-15-5
Target:  

RET VEGFR Trk Receptor c-Fms

Research Areas:  

Cancer

NPA101.3 is an orally active RET receptor tyrosine kinase and VEGFR2 inhibitor (RET IC50 = 0.001 μM, RET V804M IC50 = 0.008 μM, VEGFR2 IC50 = 0.003 μM). NPA101.3 inhibits purified TRKA (IC50 = 32 nM) and CSF1R (IC50 = 46 nM). NPA101.3 completely suppresses tumor formation in RET /C634Y-transformed cells and also attenuates tumor formation in HRAS /G12V-transformed cells. NPA101.3 can be used in the research of RET-driven cancers .
loading...
    loading...